Pharmacist-Physician Collaboration for Diabetes Care

Cardiovascular Outcomes

Amanda Howard-Thompson, Michelle Z. Farland, Debbie C. Byrd, Anita Airee, Jeremy Thomas, Jennifer Campbell, Regina Cassidy, Timothy Morgan, Katie J. Suda

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Only 23% of patients are meeting all goals for cardiovascular complications of diabetes. Objective: The purpose of our study is to evaluate the effect of a pharmacist-physician collaboration on attainment of cardiovascular-related goals in patients with type 2 diabetes. Methods: This prospective, multicenter cohort enrolled patients from 7 practice sites that were members of the University of Tennessee Pharmacist Practice Based Research Network (UT Pharm Net). Patients were included if they were diagnosed with type 2 diabetes, at least 18 years of age and English speaking. Pregnant patients were excluded. Patients were followed for 12 months after enrollment. Primary cardiovascular outcomes included reduction in systolic blood pressure, diastolic blood pressure, and low-density lipoprotein (LDL) as well as the proportion of patients achieving a blood pressure goal of <130/80 mm Hg and proportion of patients achieving an LDL goal of <100 mg/dL. Results: For the 206 patients enrolled, the average age was 59.7 years; the majority were male (59.7%) and white (66%). When compared with baseline, the postintervention mean systolic (P<.0001), diastolic blood pressure (P=.0003), and LDL (P<.0001) decreased significantly. The proportion of patients achieving a blood pressure of <130/80 mm Hg increased 21.8% (P<.0001), and the proportion of patients achieving an LDL of <100 mg/dL increased 12% (P=.0023). Conclusions: The results of our study indicate that collaborative management has a positive impact on decreasing cardiovascular risk and assists patients in attaining national goals for blood pressure and cholesterol.

Original languageEnglish (US)
Pages (from-to)1471-1477
Number of pages7
JournalAnnals of Pharmacotherapy
Volume47
Issue number11
DOIs
StatePublished - Nov 1 2013

Fingerprint

Pharmacists
Physicians
Blood Pressure
LDL Lipoproteins
Type 2 Diabetes Mellitus
Diabetes Complications
Cholesterol

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this

Howard-Thompson, A., Farland, M. Z., Byrd, D. C., Airee, A., Thomas, J., Campbell, J., ... Suda, K. J. (2013). Pharmacist-Physician Collaboration for Diabetes Care: Cardiovascular Outcomes. Annals of Pharmacotherapy, 47(11), 1471-1477. https://doi.org/10.1177/1060028013504738

Pharmacist-Physician Collaboration for Diabetes Care : Cardiovascular Outcomes. / Howard-Thompson, Amanda; Farland, Michelle Z.; Byrd, Debbie C.; Airee, Anita; Thomas, Jeremy; Campbell, Jennifer; Cassidy, Regina; Morgan, Timothy; Suda, Katie J.

In: Annals of Pharmacotherapy, Vol. 47, No. 11, 01.11.2013, p. 1471-1477.

Research output: Contribution to journalArticle

Howard-Thompson, A, Farland, MZ, Byrd, DC, Airee, A, Thomas, J, Campbell, J, Cassidy, R, Morgan, T & Suda, KJ 2013, 'Pharmacist-Physician Collaboration for Diabetes Care: Cardiovascular Outcomes', Annals of Pharmacotherapy, vol. 47, no. 11, pp. 1471-1477. https://doi.org/10.1177/1060028013504738
Howard-Thompson A, Farland MZ, Byrd DC, Airee A, Thomas J, Campbell J et al. Pharmacist-Physician Collaboration for Diabetes Care: Cardiovascular Outcomes. Annals of Pharmacotherapy. 2013 Nov 1;47(11):1471-1477. https://doi.org/10.1177/1060028013504738
Howard-Thompson, Amanda ; Farland, Michelle Z. ; Byrd, Debbie C. ; Airee, Anita ; Thomas, Jeremy ; Campbell, Jennifer ; Cassidy, Regina ; Morgan, Timothy ; Suda, Katie J. / Pharmacist-Physician Collaboration for Diabetes Care : Cardiovascular Outcomes. In: Annals of Pharmacotherapy. 2013 ; Vol. 47, No. 11. pp. 1471-1477.
@article{01d624d08503465ba50c63420d92ce65,
title = "Pharmacist-Physician Collaboration for Diabetes Care: Cardiovascular Outcomes",
abstract = "Background: Only 23{\%} of patients are meeting all goals for cardiovascular complications of diabetes. Objective: The purpose of our study is to evaluate the effect of a pharmacist-physician collaboration on attainment of cardiovascular-related goals in patients with type 2 diabetes. Methods: This prospective, multicenter cohort enrolled patients from 7 practice sites that were members of the University of Tennessee Pharmacist Practice Based Research Network (UT Pharm Net). Patients were included if they were diagnosed with type 2 diabetes, at least 18 years of age and English speaking. Pregnant patients were excluded. Patients were followed for 12 months after enrollment. Primary cardiovascular outcomes included reduction in systolic blood pressure, diastolic blood pressure, and low-density lipoprotein (LDL) as well as the proportion of patients achieving a blood pressure goal of <130/80 mm Hg and proportion of patients achieving an LDL goal of <100 mg/dL. Results: For the 206 patients enrolled, the average age was 59.7 years; the majority were male (59.7{\%}) and white (66{\%}). When compared with baseline, the postintervention mean systolic (P<.0001), diastolic blood pressure (P=.0003), and LDL (P<.0001) decreased significantly. The proportion of patients achieving a blood pressure of <130/80 mm Hg increased 21.8{\%} (P<.0001), and the proportion of patients achieving an LDL of <100 mg/dL increased 12{\%} (P=.0023). Conclusions: The results of our study indicate that collaborative management has a positive impact on decreasing cardiovascular risk and assists patients in attaining national goals for blood pressure and cholesterol.",
author = "Amanda Howard-Thompson and Farland, {Michelle Z.} and Byrd, {Debbie C.} and Anita Airee and Jeremy Thomas and Jennifer Campbell and Regina Cassidy and Timothy Morgan and Suda, {Katie J.}",
year = "2013",
month = "11",
day = "1",
doi = "10.1177/1060028013504738",
language = "English (US)",
volume = "47",
pages = "1471--1477",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "11",

}

TY - JOUR

T1 - Pharmacist-Physician Collaboration for Diabetes Care

T2 - Cardiovascular Outcomes

AU - Howard-Thompson, Amanda

AU - Farland, Michelle Z.

AU - Byrd, Debbie C.

AU - Airee, Anita

AU - Thomas, Jeremy

AU - Campbell, Jennifer

AU - Cassidy, Regina

AU - Morgan, Timothy

AU - Suda, Katie J.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Background: Only 23% of patients are meeting all goals for cardiovascular complications of diabetes. Objective: The purpose of our study is to evaluate the effect of a pharmacist-physician collaboration on attainment of cardiovascular-related goals in patients with type 2 diabetes. Methods: This prospective, multicenter cohort enrolled patients from 7 practice sites that were members of the University of Tennessee Pharmacist Practice Based Research Network (UT Pharm Net). Patients were included if they were diagnosed with type 2 diabetes, at least 18 years of age and English speaking. Pregnant patients were excluded. Patients were followed for 12 months after enrollment. Primary cardiovascular outcomes included reduction in systolic blood pressure, diastolic blood pressure, and low-density lipoprotein (LDL) as well as the proportion of patients achieving a blood pressure goal of <130/80 mm Hg and proportion of patients achieving an LDL goal of <100 mg/dL. Results: For the 206 patients enrolled, the average age was 59.7 years; the majority were male (59.7%) and white (66%). When compared with baseline, the postintervention mean systolic (P<.0001), diastolic blood pressure (P=.0003), and LDL (P<.0001) decreased significantly. The proportion of patients achieving a blood pressure of <130/80 mm Hg increased 21.8% (P<.0001), and the proportion of patients achieving an LDL of <100 mg/dL increased 12% (P=.0023). Conclusions: The results of our study indicate that collaborative management has a positive impact on decreasing cardiovascular risk and assists patients in attaining national goals for blood pressure and cholesterol.

AB - Background: Only 23% of patients are meeting all goals for cardiovascular complications of diabetes. Objective: The purpose of our study is to evaluate the effect of a pharmacist-physician collaboration on attainment of cardiovascular-related goals in patients with type 2 diabetes. Methods: This prospective, multicenter cohort enrolled patients from 7 practice sites that were members of the University of Tennessee Pharmacist Practice Based Research Network (UT Pharm Net). Patients were included if they were diagnosed with type 2 diabetes, at least 18 years of age and English speaking. Pregnant patients were excluded. Patients were followed for 12 months after enrollment. Primary cardiovascular outcomes included reduction in systolic blood pressure, diastolic blood pressure, and low-density lipoprotein (LDL) as well as the proportion of patients achieving a blood pressure goal of <130/80 mm Hg and proportion of patients achieving an LDL goal of <100 mg/dL. Results: For the 206 patients enrolled, the average age was 59.7 years; the majority were male (59.7%) and white (66%). When compared with baseline, the postintervention mean systolic (P<.0001), diastolic blood pressure (P=.0003), and LDL (P<.0001) decreased significantly. The proportion of patients achieving a blood pressure of <130/80 mm Hg increased 21.8% (P<.0001), and the proportion of patients achieving an LDL of <100 mg/dL increased 12% (P=.0023). Conclusions: The results of our study indicate that collaborative management has a positive impact on decreasing cardiovascular risk and assists patients in attaining national goals for blood pressure and cholesterol.

UR - http://www.scopus.com/inward/record.url?scp=84889004154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889004154&partnerID=8YFLogxK

U2 - 10.1177/1060028013504738

DO - 10.1177/1060028013504738

M3 - Article

VL - 47

SP - 1471

EP - 1477

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 11

ER -